Page 197 - Read Online

Y, Sakai N, Takami T. Diagnostic utility of CSF soluble CD27 for Schmiegel W, Hahn S, Schroers R. Identification of microRNAs in
primary central nervous system lymphoma in immunocompetent the cerebrospinal fluid as biomarker for the diagnosis of glioma.
patients. Neurol Res 2000;22:434-42. Neuro Oncol 2012;14:29-33.
112. Pantazis G, Psaras T, Krope K, von Coelln R, Fend F, Bock T, 116. Teplyuk NM, Mollenhauer B, Gabriely G, Giese A, Kim E, Smolsky
Schittenhelm J, Melms A, Meyermann R, Bornemann A. Cerebral M, Kim RY, Saria MG, Pastorino S, Kesari S, Krichevsky AM.
low-grade lymphoma and light chain deposition disease: exceedingly MicroRNAs in cerebrospinal fluid identify glioblastoma and
high IgG levels in the cerebrospinal fluid as a diagnostic clue. Clin metastatic brain cancers and reflect disease activity. Neuro Oncol
Neuropathol 2010;29:378-83. 2012;14:689-700.
113. Yang H, Cai L, Zhang Y, Tan H, Deng Q, Zhao M, Xu X. Sensitive 117. Shi R, Wang PY, Li XY, Chen JX, Li Y, Zhang XZ, Zhang CG,
detection of EGFR mutations in cerebrospinal fluid from lung Jiang T, Li WB, Ding W, Cheng SJ. Exosomal levels of miRNA-21
adenocarcinoma patients with brain metastases. J Mol Diagn from cerebrospinal fluids associated with poor prognosis and tumor
2014;16:558-63. recurrence of glioma patients. Oncotarget 2015;6:26971-81.
114. Shnaper S, Desbaillets I, Brown DA, Murat A, Migliavacca E, 118. Drusco A, Bottoni A, Lagana A, Acunzo M, Fassan M, Cascione
Schluep M, Ostermann S, Hamou MF, Stupp R, Breit SN, de Tribolet L, Antenucci A, Kumchala P, Vicentini C, Gardiman MP, Alder
N, Hegi ME. Elevated levels of MIC-1/GDF15 in the cerebrospinal H, Carosi MA, Ammirati M, Gherardi S, Luscri M, Carapella C,
fluid of patients are associated with glioblastoma and worse outcome. Zanesi N, Croce CM. A differentially expressed set of microRNAs
Int J Cancer 2009;125:2624-30. in cerebro-spinal fluid (CSF) can diagnose CNS malignancies.
115. Baraniskin A, Kuhnhenn J, Schlegel U, Maghnouj A, Zollner H, Oncotarget 2015;6:20829-39.

Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ May 18, 2016 ¦ 187